Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial - Publication - Bridge of Knowledge

Search

Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial

Abstract

Citations

  • 1 2 3

    CrossRef

  • 0

    Web of Science

  • 1 2 6

    Scopus

Authors (25)

  • Photo of  Marek Trněný

    Marek Trněný

  • Photo of  Thierry Lamy

    Thierry Lamy

  • Photo of  Jan Walewski

    Jan Walewski

  • Photo of  David Belada

    David Belada

  • Photo of  Jiri Mayer

    Jiri Mayer

  • Photo of  John Radford

    John Radford

  • Photo of MD, PhD, Prof Wojciech Jurczak

    Wojciech Jurczak MD, PhD, Prof

  • Photo of  Franck Morschhauser

    Franck Morschhauser

  • Photo of  Julia Alexeeva

    Julia Alexeeva

  • Photo of  Simon Rule

    Simon Rule

  • Photo of  Boris Afanasyev

    Boris Afanasyev

  • Photo of  Kamil Kaplanov

    Kamil Kaplanov

  • Photo of  Antoine Thyss

    Antoine Thyss

  • Photo of  Alexej Kuzmin

    Alexej Kuzmin

  • Photo of  Sergey Voloshin

    Sergey Voloshin

  • Photo of  Kazimierz Kuliczkowski

    Kazimierz Kuliczkowski

  • Photo of  Agnieszka Giza

    Agnieszka Giza

  • Photo of  Noel Milpied

    Noel Milpied

  • Photo of  Caterina Stelitano

    Caterina Stelitano

  • Photo of  Reinhard Marks

    Reinhard Marks

  • Photo of  Lorenz Trümper

    Lorenz Trümper

  • Photo of  Tsvetan Biyukov

    Tsvetan Biyukov

  • Photo of  Meera Patturajan

    Meera Patturajan

  • Photo of  Marie-Laure Bravo

    Marie-Laure Bravo

  • Photo of  Luca Arcaini

    Luca Arcaini

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
LANCET ONCOLOGY no. 17, edition 3, pages 319 - 331,
ISSN: 1470-2045
ISSN:
1470-2045
Publication year:
2016
DOI:
Digital Object Identifier (open in new tab) 10.1016/s1470-2045(15)00559-8
Verified by:
No verification

seen 53 times

Meta Tags